Questions? +1 (202) 540-8337 Login
Trusted News Since 1995
A service for global professionals · Tuesday, May 22, 2018 · 448,117,052 Articles · 3+ Million Readers

Smoothened Homolog (Protein Gx or SMO) - Pipeline and Therapeutics Review, H1 2018

Smoothened Homolog

PUNE, MAHARASHTRA, INDIA, February 19, 2018 / -- Smoothened Homolog


Smoothened Homolog (Protein Gx or SMO) - Smoothened homolog (SMO) is a G protein-coupled receptor that probably associates with the patched protein (PTCH) to transduce the hedgehog's proteins signal. Binding of sonic hedgehog (SHH) to its receptor is thought to prevent normal inhibition by patched of smoothened (SMO). It is required for the accumulation of KIF7 and GLI3 in the cilia..

Click here for sample report @

Top Companies mentioned

BeiGene Ltd

Genentech Inc

Ignyta Inc

IMPACT Therapeutics Inc

Mayne Pharma Group Ltd

Pfizer Inc

Sun Pharma Advanced Research Company Ltd

Smoothened Homolog Industry Major Outlook

Pharmaceutical and Healthcare latest pipeline guide Smoothened Homolog - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Smoothened Homolog, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The report also reviews key players involved in Smoothened Homolog (Protein Gx or SMO) targeted therapeutics development with respective active and dormant or discontinued projects. Currently, The molecules developed by companies in Phase II, Preclinical and Discovery stages are 6, 2 and 1 respectively.

Similarly, the universities portfolio in Preclinical and Discovery stages comprises 2 and 1 molecules, respectively. Report covers products from therapy areas Oncology, Genetic Disorders, Gastrointestinal and Undisclosed which include indications Medulloblastoma,  and Acute Lymphocytic Leukem.

Smoothened Homolog - Competitive Analysis

Key players are making innovative developments in Smoothened Homolog industry.  The same will help in improving the market performance. Heavy investments are made by major players in the R&D sector


The pipeline guide provides a snapshot of the global therapeutic landscape of Smoothened Homolog.

The pipeline guide reviews pipeline therapeutics for Smoothened Homolog by companies and universities/research institutes based on information derived from company and industry-specific sources.

The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. 

The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

The pipeline guide reviews key companies involved in Smoothened Homolog therapeutics and enlists all their major and minor projects.

The pipeline guide evaluates Smoothened Homolog therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

The pipeline guide encapsulates all the dormant and discontinued pipeline projects. 

The pipeline guide reviews latest news related to pipeline therapeutics for Smoothened Homolog.


For Detailed Reading Please visit @

About Us

Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

Contact Us:


Partner Relations & Marketing Manager

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here

Powered by EIN Presswire